RE: RE: RE: BUYOUT!!!Time to CHIME IN.
Buyout Offer. Board of directors have to do what is in the best interest of the share holders. (conflict of interests sometimes) They have to look at the current BOOK value of the company and make an offer that would satisify MOST investors. Also they have to look at the amount of money invested in the development of the company, along with expected appreciation on investment. Pharmagap was once trading @ 3.00 per share, now there has been dilution, but I believe that the only reason we are not at those values is Economics. Supply & Demand.
Hostile Take Over: I would personally like this. It means they will have to buy up shares in the open market to gain a majority share that outweighs share holders interest. so if all of a sudden we see 10'000'000 shares go through a day over the course of the month, we will see major share appreciation. And those who hold out, will make out like bandits or get stuck holding the bag. Penny flippers will make their pennies, but wont be able to get back in because everything is being sucked up.
Licencing: Would see a good jump in share price. Pharmagap does not have what it take to bring this product to market. They NEED a partner. If the right partner (glaxo, biovail, etc...) came in it would give additional credibility to the product, and the partnership would be in a win win situation on share appreciation.
Hope this helps some newer investors.